Jennifer K Simpson, Ph.D., MSN, CRNP
President and Chief Executive Officer
Dr. Simpson joined Sun BioPharma as President and Chief Executive Officer in July of 2020 and was also appointed as a Director at that time. She brings to the Company more than 12 years’ experience in pharmaceutical executive leadership, global marketing and product commercialization. Most recently Dr. Simpson was the CEO of Delcath (Nasdaq:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancer.
She joined Delcath as Executive Vice President, Global Marketing in March 2012 and held various leadership positions there including interim President and CEO in 2014 until her promotion to CEO in 2015. From 2008 to 2012, Dr. Simpson served in various product leadership roles, including Vice President, Global Marketing, Oncology Brand Lead at ImClone Systems, Inc. (a wholly owned subsidiary of Eli Lilly and Company (NYSE:LLY)). From 2006 to 2008, Dr. Simpson held the position of Product Director, Oncology Therapeutics Marketing at Ortho Biotech (now Janssen Biotech), a biotechnology company focused on innovative solutions in immunology, oncology and nephrology. Earlier in her career, Dr. Simpson spent over a decade as a hematology/oncology nurse practitioner and educator. She has served on the Board of Directors and Nominating and Corporate Governance Committee of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) since 2019. Dr. Simpson earned a Ph.D. in Epidemiology from the University of Pittsburgh, an M.S. in Nursing from the University of Rochester, and a B.S. in Nursing from the State University of New York at Buffalo.
Michael T. Cullen, M.D., MBA
Co-Founder, Executive Chairman
Dr. Cullen has served as Executive Chairman of the board and as a director of our Company since September 2015. He resumed responsibilities as President and Chief Executive Officer of the Company in October 2018. Dr. Cullen brings 30 years of pharmaceutical experience to our Company, including expertise in working with development-stage companies in planning, designing and advancing drug candidates from preclinical through clinical development.
Vice President and Chief Financial Officer
Ms. Horvath has held both finance and operating positions within pharmaceutical, healthcare and consumer organizations. Most recently she served as Chief Financial Officer of Eyebobs, LLC, a private company focused on the reading glasses industry. Prior to that, Ms. Horvath served as Vice President and Chief Financial Officer of Tenacious Holdings, Inc. (d/b/a ergodyne)…
Thomas X. Neenan, Ph.D.
Co-Founder and Chief Scientific Officer
Dr. Neenan is an entrepreneur and scientist with extensive chemistry and business development executive experience with AT&T Bell Labs, Geltex, Genzyme, Warwick Effect Polymers, and Proxy Biomedical. Prior to Sun BioPharma, Dr. Neenan was the founding CEO and served as Chief Technology Officer of Sideris Pharmaceuticals Inc, raising $32M in equity financing in 2013.
Suzanne Gagnon, M.D.
Chief Medical Officer
Dr. Gagnon has served as our Chief Medical Officer and as a director of our Company since September 2015. Dr. Gagnon had previously served as a director of Sun BioPharma Research, Inc. (“SBR”), a former affiliate of the Company, since June 2015 and as its Chief Medical Officer since January 2015. Previously, Dr. Gagnon served as the Lead Clinical Consultant to the Company.
Vice President of Operations
Since April 2012, Ms. Groene has provided administrative support and operational management to the Sun BioPharma, Inc. team. Prior to joining Sun BioPharma, Inc., Ms. Groene worked for MGI Pharma, Inc. as the Executive Assistant to the Chief Medical Officer then transitioned into the Marketing Department. Ms. Groene earned her Bachelor of Science degree from St. Cloud State University in St. Cloud, Minnesota.
Anthony L. Kiorpes, Ph.D., DVM
Andy Kiorpes is a graduate of Columbia University (BA Biology, 1970), the University of Wisconsin-Madison (MS Veterinary Science, 1974; PhD Physiology, 1977) Kansas State University (DVM, 1982), and the University of Arkansas (MBA, 1999). He has over 22 years of experience as a toxicologist working in food, pharmaceutical, and medical device development and safety.
Michael Walker, M.D.
Pancreatic Research Consultant
Dr. Michael Walker obtained his BS (Biochemistry) and MD degrees from the University of Minnesota. He completed his General Surgery residency and a 2-year American Cancer Society clinical and research fellowship at UCLA, focusing on pancreatic islets and their molecular physiology. Before joining Sun BioPharma, he practiced General Surgery in Minnesota.
Kristen Flaharty, PharmD
Dr. Kristen Flaharty, a board certified Clinical Pharmacologist, has been a consultant to the pharmaceutical industry, for the past 20 years, primarily involved in clinical pharmacology and regulatory aspects of pharmaceutical development. Dr. Flaharty has presented clinical development plans and pre-registration packages at FDA’s Center for Drug Evaluation and Research on behalf of sponsors…